Terminalia catappa Extract Palliates Redox Imbalance and Inflammation in Diabetic Rats by Upregulating Nrf-2 Gene
- PMID: 34956587
- PMCID: PMC8702315
- DOI: 10.1155/2021/9778486
Terminalia catappa Extract Palliates Redox Imbalance and Inflammation in Diabetic Rats by Upregulating Nrf-2 Gene
Abstract
This study aims at evaluating the ameliorative role of Terminalia catappa aqueous leaf extract (TCA) on hyperglycaemia-induced oxidative stress and inflammation in a high-fat, low dose streptozotocin-induced type 2 diabetic rat model. Experimental rats were treated orally with 400 and 800 mg/kg bw TCA daily for four weeks. Antioxidant enzyme activities, plasma glucose concentration, protein concentration, oxidative stress, and inflammation biomarkers were assayed using standard methods. Hepatic relative expressions of tumour necrosis factor-alpha (TNF-α), interleukin-six (IL-6), and nuclear factor-erythroid 2 related factor 2 (Nrf-2) were also assessed. Molecular docking and prediction of major TCA phytoconstituents' biological activity related to T2DM-induced oxidative stress were evaluated in silico. Induction of diabetes significantly (p < 0.05) reduced superoxide dismutase, glutathione-S-transferase, and peroxidase activities. Glutathione and protein stores were significantly (p < 0.05) depleted, while glucose, MDA, interleukin-six (IL-6), and tumour necrosis factor-α (TNF-α) concentrations were significantly (p < 0.05) increased. A significant (p < 0.05) upregulation of hepatic TNF-α and IL-6 expression and downregulation (p < 0.05) of Nrf-2 expression were observed during diabetes onset. TCA treatment significantly (p < 0.05) modulated systemic diabetic-induced oxidative stress and inflammation, mRNA expression dysregulation, and dysregulated macromolecule metabolism. However, only 800 mg/kg TCA treatment significantly (p < 0.05) downregulated hepatic TNF-α expression. 9-Oxabicyclo[3.3.1]nonane-2,6-diol and 1,2,3-Benzenetriol bound comparably to glibenclamide in Nrf-2, IL-6, and TNF-α binding pockets. They were predicted to be GST A and M substrate, JAK2 expression, ribulose-phosphate 3-epimerase, NADPH peroxidase, and glucose oxidase inhibitors. These results suggest that TCA ameliorates hyperglycaemia-induced oxidative stress and inflammation by activating Nrf-2 gene.
Copyright © 2021 Franklyn Nonso Iheagwam et al.
Conflict of interest statement
The authors declare that they have no actual or potential competing financial interest.
Figures
References
-
- Iheagwam F. N., Israel E. N., Kayode K. O., De Campos O. C., Ogunlana O. O., Chinedu S. N. GC-MS analysis and inhibitory evaluation of Terminalia catappa leaf extracts on major enzymes linked to diabetes. Evidence-Based Complementary and Alternative Medicine . 2019;2019 doi: 10.1155/2019/6316231.6316231 - DOI - PMC - PubMed
-
- Yesufu J. O., Oluwasile O. D., Oluranti O. I., Fasanmade A. A., Soladoye A. O. Cardiopulmonary health indices and diabetes risk scores in undergraduate students of a private university in Nigeria. Beni-Suef University Journal of Basic and Applied Sciences . 2020;9(1):1–7. doi: 10.1186/s43088-019-0032-x. - DOI
-
- International Diabetes Federation. IDF Diabetes Atlas . 9th. Brussels, Belgium: IDF; 2019. - PubMed
-
- Koch M. Urbanisation, inequality, and non-communicable disease risk. The Lancet Diabetes and Endocrinology, . 2017;5(5):p. 313. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
